Yancheng Lai, Xiaole Lu, Yankai Liao, et al. Crosstalk between glioblastoma and tumor microenvironment drives proneural–mesenchymal transition through ligand-receptor interactions. [J]. Genes & Diseases 11(2).(2024)
DOI:
Yancheng Lai, Xiaole Lu, Yankai Liao, et al. Crosstalk between glioblastoma and tumor microenvironment drives proneural–mesenchymal transition through ligand-receptor interactions. [J]. Genes & Diseases 11(2).(2024) DOI: 10.1016/j.gendis.2023.05.025.
Crosstalk between glioblastoma and tumor microenvironment drives proneural–mesenchymal transition through ligand-receptor interactions
摘要
Abstract
Glioblastoma (GBM) is the most common intrinsic and aggressive primary brain tumor in adults
with a median survival of approximately 15 months. GBM heterogeneity is considered responsible for the treatment resistance and unfavorable prognosis. Proneural-mesenchymal transition (PMT) represents GBM malignant progression and recurrence
which might be a breakthrough to understand GBM heterogeneity and overcome treatment resistance. PMT is a complicated process influenced by crosstalk between GBM and tumor microenvironment
depending on intricate ligand-receptor interactions. In this review
we summarize the autocrine and paracrine pathways in the GBM microenvironment and related ligand-receptor interactions inducing PMT. We also discuss the current therapies targeting the PMT-related autocrine and paracrine pathways. Together
this review offers a comprehensive understanding of the failure of GBM-targeted therapy and ideas for future tendencies of GBM treatment.